» Articles » PMID: 6497467

Anticardiolipin Antibodies: Occurrence in Behçet's Syndrome

Overview
Journal Ann Rheum Dis
Specialty Rheumatology
Date 1984 Oct 1
PMID 6497467
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Anticardiolipin antibodies have recently been described in association with arterial and venous thrombosis, and with neurological symptoms, in connective tissue diseases. In a study of 70 patients with Behçet's syndrome 13 patients had these antibodies. Of these 13 patients eight had a history of either retinal vascular pathology, cerebral infarction, or thrombophlebitis. The association of retinal vascular disease and the presence of anticardiolipin antibodies was statistically significant.

Citing Articles

Prevalence of antiphospholipid antibodies in Behçet's disease: A systematic review and meta-analysis.

Islam M, Alam S, Kundu S, Prodhan A, Khandker S, Reshetnyak T PLoS One. 2020; 15(1):e0227836.

PMID: 31929597 PMC: 6957187. DOI: 10.1371/journal.pone.0227836.


Inhibition of SA Node at Supine Position in Right Atrial Thrombus Complicating Behçet's Disease - From Cardiac Surgical Point of View.

Hijazi E, Ibdah R, Rawashdeh S, Saadeh A, Al-Balas H Am J Case Rep. 2016; 17:412-6.

PMID: 27311379 PMC: 4917071. DOI: 10.12659/ajcr.897998.


Antiphospholipid antibodies predict progression of abdominal aortic aneurysms.

Duftner C, Seiler R, Dejaco C, Chemelli-Steingruber I, Schennach H, Klotz W PLoS One. 2014; 9(6):e99302.

PMID: 24979700 PMC: 4076179. DOI: 10.1371/journal.pone.0099302.


Behçet's Disease, Associated Large Vessel Thrombosis, and Coexistent Thrombophilia: A Distinct Nosological Entity?.

Stoimenis D, Petridis N, Papaioannou N Case Rep Med. 2013; 2013:740837.

PMID: 24151511 PMC: 3789308. DOI: 10.1155/2013/740837.


Activated protein C resistance in Behcet's disease.

Abdel Badaee H, Edrees A, Amin S, El Amir M, Ragab G Thromb J. 2013; 11(1):17.

PMID: 24004911 PMC: 3846854. DOI: 10.1186/1477-9560-11-17.


References
1.
Mason R, Barnes C . Behçet's syndrome with arthritis. Ann Rheum Dis. 1969; 28(2):95-103. PMC: 1031118. DOI: 10.1136/ard.28.2.95. View

2.
Bluestein H, Zvaifler N . Brain-reactive lymphocytotoxic antibodies in the serum of patients with systemic lupus erythematosus. J Clin Invest. 1976; 57(2):509-16. PMC: 436676. DOI: 10.1172/JCI108303. View

3.
Bresnihan B, Oliver M, Grigor R, Hughes G . Brain reactivity of lymphocytotoxic antibodies in systemic lupus erythematosus with and without cerebral involvement. Clin Exp Immunol. 1977; 30(3):333-7. PMC: 1541136. View

4.
Bluestein H . Neurocytotoxic antibodies in serum of patients with systemic lupus erythematosus. Proc Natl Acad Sci U S A. 1978; 75(8):3965-9. PMC: 392910. DOI: 10.1073/pnas.75.8.3965. View

5.
Bresnihan B, Oliver M, Williams B, Hughes G . An antineuronal antibody cross-reacting with erythrocytes and lymphocytes in systemic lupus erythematosus. Arthritis Rheum. 1979; 22(4):313-20. DOI: 10.1002/art.1780220401. View